|Day Low/High||64.55 / 65.20|
|52 Wk Low/High||49.59 / 75.00|
Elliott's previous successes in the healthcare space bode well for its chances at athena.
Survey measures employees' likelihood to refer candidates to their company
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABDC, BCBP, CERN, DVA, EDGW, GRUB, INS, LRN, MET, NC, NEWS, OAK Downgrades: ANIP, BBSI, CVG, FRAN, FTD, MHLD, PHX Initiations: NVTR, SNDX Read on to get TheStreet Quant Ratings' detailed report:
The most recent short interest data has been released for the 02/28/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Here are Friday's top research calls, including an upgrade for Ford and downgrades for Intel, Twitter and Viacom.
A giant in the medical information systems sector, Cerner finished within the company guidance for the year and revenues were rescued by increased service, support and maintenance work.
Under the advice of Paul Singer, the provider of technology and consulting services, Advisory Board, is working with Goldman Sachs and Allen & Co. to weigh its options.
The online health platform's prognosis is bleak, and the stock may not recover, unless it becomes an acquisition target.